Cargando…
Inhibitors of MAO-A and MAO-B in Psychiatry and Neurology
Inhibitors of MAO-A and MAO-B are in clinical use for the treatment of psychiatric and neurological disorders respectively. Elucidation of the molecular structure of the active sites of the enzymes has enabled a precise determination of the way in which substrates and inhibitor molecules are metabol...
Autores principales: | Finberg, John P. M., Rabey, Jose M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5067815/ https://www.ncbi.nlm.nih.gov/pubmed/27803666 http://dx.doi.org/10.3389/fphar.2016.00340 |
Ejemplares similares
-
Pharmacology of Rasagiline, a New MAO-B Inhibitor Drug for the Treatment of Parkinson’s Disease with Neuroprotective Potential
por: Finberg, John P.M.
Publicado: (2010) -
Reversible Small Molecule Inhibitors of MAO A and MAO B with Anilide Motifs
por: Hagenow, Jens, et al.
Publicado: (2020) -
Maó
por: Quintana, Josep M. (Josep Maria)
Publicado: (1996) -
MAO-inhibitors in Parkinson's Disease
por: Riederer, Peter, et al.
Publicado: (2011) -
Mao : a biography /
por: Terrill, Ross
Publicado: (1981)